PRINCETON, N.J., Oct. 21 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a specialty medical device/pharmaceutical company focusing on advanced wound care, today announced that eleven clinical case series regarding its flagship product, MEDIHONEY®, will be presented at the upcoming October 22-25 Clinical Symposium on Advances in Skin & Wound Care in San Antonio. These presentations include:
"Active Leptospermum Honey and Negative Pressure Wound Therapy for Non-Healing Post-Surgical Wounds"
Edna Acuna, MD
Medical Director, Wound & Hyperbaric Clinic, Methodist Medical Center, Dallas, TX
"Honey under Negative Pressure Wound Therapy: A New Approach to Removing Devitalized Tissue"
Paul A. Ligouri, MD, Kim L. Peters, RN, CWS, Jolene Bowars, RN, and Sandra Senno, MD
Haverhill Rehabilitation Hospital, Haverhill, MA
"Use of Honey Dressings for Infected Left Ventricular Assist Device Wounds"
Genevieve O'Shea, BN, RN, CCRN and Kathleen Lockard, BSN, RN, MBA
Artificial Heart Program, University of Pittsburgh, Pittsburgh, PA
"Evidence Based Practice for Pediatric Wound Care: Utilizing Active Leptospermum Honey as a Primary Dressing for Chronic Wounds"
Charlene Deo, RN, CWOCN
Lucile Packard Childrens Hospital at Stanford, Palo Alto, CA
"Active Leptospermum Honey for Pediatric Wound Care: Moving Evidence into Practice"
Roxana Reyna, RNC, WCC
Driscoll Children's Hospital, Corpus Christi, TX
"The Clinical Benefits of Active Leptospermum Honey: Oncologic Wounds"
Debbie Segovia, RN, MSN, CWOCN
|SOURCE Derma Sciences, Inc.|
Copyright©2009 PR Newswire.
All rights reserved